Zachary S Wallace

InstitutionHarvard Medical School
AddressBoston
Massachusetts
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 30 Covid-19 publications, with a maximum of 4 publications in January 2021 and May 2021
    All Publications
    Bar chart showing 64 publications over 11 distinct years, with a maximum of 17 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sparks JA, Wallace ZS, Robinson PC. Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Curr Opin Rheumatol. 2021 09 01; 33(5):412-418. PMID: 34171857.
      Citations:    Fields:    Translation:Humans
    2. Wallace ZS, Sparks JA, Robinson PC, Machado PM, Yazdany J. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by Sparks et al. Ann Rheum Dis. 2021 Aug 23. PMID: 34426400.
      Citations:    Fields:    
    3. Sparks JA, Wallace ZS, Seet AM, Robinson PC, Machado PM, Yazdany J. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by Sparks et al. Ann Rheum Dis. 2021 Aug 13. PMID: 34389604.
      Citations:    Fields:    
    4. Hausmann JS, Kennedy K, Simard JF, Liew JW, Sparks JA, Moni TT, Harrison C, Larché MJ, Levine M, Sattui SE, Semalulu T, Foster G, Surangiwala S, Thabane L, Beesley RP, Durrant KL, Mateus EF, Mingolla S, Nudel M, Palmerlee CA, Richards DP, Liew DFL, Hill CL, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Sirotich E. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. Lancet Rheumatol. 2021 Oct; 3(10):e707-e714. PMID: 34316727.
      Citations: 3     
    5. Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D'Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer M, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, et al. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146. PMID: 34049860.
      Citations: 16     Fields:    Translation:Humans
    6. Hsu TY, D'Silva KM, Patel NJ, Wang J, Mueller AA, Fu X, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Cook C, Choi HK, Zhang Y, Gravallese EM, Wallace ZS, Sparks JA. Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study. Lancet Rheumatol. 2021 Sep; 3(9):e638-e647. PMID: 34095857.
      Citations: 4     
    7. D'Silva KM, Jorge A, Cohen A, McCormick N, Zhang Y, Wallace ZS, Choi HK. COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study. Arthritis Rheumatol. 2021 06; 73(6):914-920. PMID: 33305544.
      Citations: 20     Fields:    Translation:Humans
    8. D'Silva KM, Wallace ZS. COVID-19 and rheumatoid arthritis. Curr Opin Rheumatol. 2021 05 01; 33(3):255-261. PMID: 33625043.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    9. D'Silva KM, Wallace ZS. COVID-19 and Disease-Modifying Anti-rheumatic Drugs. Curr Rheumatol Rep. 2021 04 24; 23(5):28. PMID: 33893890.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    10. Hsu TY, D'Silva KM, Patel NJ, Fu X, Wallace ZS, Sparks JA. Incident systemic rheumatic disease following COVID-19. Lancet Rheumatol. 2021 Jun; 3(6):e402-e404. PMID: 33842894.
      Citations: 2     
    11. D'Silva KM, Serling-Boyd N, Hsu TY, Sparks JA, Wallace ZS. Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by Shanoj et al. Ann Rheum Dis. 2021 Mar 10. PMID: 33692020.
      Citations: 2     Fields:    
    12. Robinson LB, Wang L, Fu X, Wallace ZS, Long AA, Zhang Y, Camargo CA, Blumenthal KG. COVID-19 severity in asthma patients: a multi-center matched cohort study. J Asthma. 2021 Mar 02; 1-14. PMID: 33650461.
      Citations: 4     Fields:    
    13. Gianfrancesco MA, Leykina LA, Izadi Z, Taylor T, Sparks JA, Harrison C, Trupin L, Rush S, Schmajuk G, Katz P, Jacobsohn L, Hsu TY, D'Silva KM, Serling-Boyd N, Wallwork R, Todd DJ, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Machado PM, Robinson PC, Yazdany J. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol. 2021 03; 73(3):374-380. PMID: 33146001.
      Citations: 12     Fields:    Translation:Humans
    14. Falk A, Benda A, Falk P, Steffen S, Wallace Z, Høeg TB. COVID-19 Cases and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August 31-November 29, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):136-140. PMID: 33507890.
      Citations: 39     Fields:    Translation:HumansPHPublic Health
    15. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 07; 80(7):930-942. PMID: 33504483.
      Citations: 85     Fields:    Translation:Humans
    16. D'Silva KM, Serling-Boyd N, Hsu TY, Sparks JA, Wallace ZS. SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease. Ann Rheum Dis. 2021 Jan 12. PMID: 33436385.
      Citations: 2     Fields:    
    17. Liew JW, Bhana S, Costello W, Hausmann JS, Machado PM, Robinson PC, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Grainger R. The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice. Rheumatology (Oxford). 2021 01 05; 60(1):353-358. PMID: 32789449.
      Citations: 5     Fields:    Translation:Humans
    18. Jorge A, D'Silva KM, Cohen A, Wallace ZS, McCormick N, Zhang Y, Choi HK. Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study. Lancet Rheumatol. 2021 Feb; 3(2):e131-e137. PMID: 33392516.
      Citations: 16     
    19. Serling-Boyd N, D'Silva KM, Hsu TY, Wallwork R, Fu X, Gravallese EM, Jorge AM, Zhang Y, Choi H, Sparks JA, Wallace ZS. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic. Ann Rheum Dis. 2021 05; 80(5):660-666. PMID: 33257496.
      Citations: 22     Fields:    Translation:Humans
    20. Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2021 01; 73(1):36-47. PMID: 32741139.
      Citations: 19     Fields:    Translation:Humans
    21. Dua AB, Kilian A, Grainger R, Fantus SA, Wallace ZS, Buttgereit F, Jonas BL. Challenges, collaboration, and innovation in rheumatology education during the COVID-19 pandemic: leveraging new ways to teach. Clin Rheumatol. 2020 Dec; 39(12):3535-3541. PMID: 33067772.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    22. Winthrop KL, Brunton AE, Beekmann S, Polgreen P, Baddley J, Saag KG, Calabrese C, Calabrese L, Robinson PC, Wallace ZS, Curtis JR. SARS CoV-2 infection among patients using immunomodulatory therapies. Ann Rheum Dis. 2021 02; 80(2):269-271. PMID: 32759259.
      Citations: 14     Fields:    Translation:Humans
    23. Kilian A, Chock YP, Huang IJ, Graef ER, Upton LA, Khilnani A, Krupnikova SDS, Almaghlouth I, Cappelli LC, Fernandez-Ruiz R, Frankel BA, Frankovich J, Harrison C, Kumar B, Monga K, Vega JAR, Singh N, Sparks JA, Sullo E, Young KJ, Duarte-Garcia A, Putman M, Johnson S, Grainger R, Wallace ZS, Liew JW, Jayatilleke A. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review. Semin Arthritis Rheum. 2020 10; 50(5):1191-1201. PMID: 32931985.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    24. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu TY, Sparks JA, Wallace ZS. Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al. Ann Rheum Dis. 2020 Jul 13. PMID: 32660976.
      Citations:    Fields:    
    25. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS. Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al. Ann Rheum Dis. 2020 Jun 25. PMID: 32586919.
      Citations:    Fields:    
    26. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS. Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao et al. Ann Rheum Dis. 2021 05; 80(5):e64. PMID: 32546600.
      Citations:    Fields:    Translation:Humans
    27. Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology (Oxford). 2020 06 01; 59(6):1204-1206. PMID: 32374851.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    28. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020 07; 79(7):859-866. PMID: 32471903.
      Citations: 276     Fields:    Translation:HumansCellsPHPublic Health
    29. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'. Ann Rheum Dis. 2020 09; 79(9):1156-1162. PMID: 32457048.
      Citations: 66     Fields:    Translation:HumansCellsPHPublic Health
    30. Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, Sufka P, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann JS, Costello W, Robinson P, Machado PM, Yazdany J. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol. 2020 May; 2(5):e250-e253. PMID: 32309814.
      Citations: 79     
    Wallace's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (156)
    Explore
    _
    Co-Authors (180)
    Explore
    _
    Similar People (60)
    Explore
    _